Search research articles
Contact Us
Filters
Showing results (281-290 of 298) with videos related to
Page
of 30
Sort By:
Plos Genetics
|
March 29, 2008
A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci
Ying Liu, Cynthia Helms, Wilson Liao, et al.
The Journal of Allergy and Clinical Immunology
|
September 9, 2018
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
Emma Guttman-Yassky, Robert Bissonnette, Benjamin Ungar, et al.
American Journal of Human Genetics
|
April 24, 2012
PSORS2 is due to mutations in CARD14
Catherine T Jordan, Li Cao, Elisha D O Roberson, et al.
The Journal of Investigative Dermatology
|
February 24, 2020
A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)
Joel M Gelfand, Daniel B Shin, Kristina Callis Duffin, et al.
American Journal of Human Genetics
|
April 24, 2012
Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis
Catherine T Jordan, Li Cao, Elisha D O Roberson, et al.
Circulation. Cardiovascular Imaging
|
May 20, 2018
Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled Trial
Nehal N Mehta, Daniel B Shin, Aditya A Joshi, et al.
Journal of the American Academy of Dermatology
|
November 4, 2004
Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne
John J DiGiovanna, Craig B Langman, Eduardo H Tschen, et al.
Nature Genetics
|
January 27, 2009
Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways
Rajan P Nair, Kristina Callis Duffin, Cynthia Helms, et al.
The New England Journal of Medicine
|
October 1, 2015
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
Mark Lebwohl, Bruce Strober, Alan Menter, et al.
Journal of the American Academy of Dermatology
|
December 3, 2016
From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis
April W Armstrong, Michael P Siegel, Jerry Bagel, et al.
Page
of 30
Search research articles
Search
Showing results (281-290 of 298) with videos related to
Sort By:
Page
of 30
Plos Genetics
|
March 29, 2008
A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci
Ying Liu, Cynthia Helms, Wilson Liao, et al.
The Journal of Allergy and Clinical Immunology
|
September 9, 2018
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
Emma Guttman-Yassky, Robert Bissonnette, Benjamin Ungar, et al.
American Journal of Human Genetics
|
April 24, 2012
PSORS2 is due to mutations in CARD14
Catherine T Jordan, Li Cao, Elisha D O Roberson, et al.
The Journal of Investigative Dermatology
|
February 24, 2020
A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)
Joel M Gelfand, Daniel B Shin, Kristina Callis Duffin, et al.
American Journal of Human Genetics
|
April 24, 2012
Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis
Catherine T Jordan, Li Cao, Elisha D O Roberson, et al.
Circulation. Cardiovascular Imaging
|
May 20, 2018
Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled Trial
Nehal N Mehta, Daniel B Shin, Aditya A Joshi, et al.
Journal of the American Academy of Dermatology
|
November 4, 2004
Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne
John J DiGiovanna, Craig B Langman, Eduardo H Tschen, et al.
Nature Genetics
|
January 27, 2009
Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways
Rajan P Nair, Kristina Callis Duffin, Cynthia Helms, et al.
The New England Journal of Medicine
|
October 1, 2015
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
Mark Lebwohl, Bruce Strober, Alan Menter, et al.
Journal of the American Academy of Dermatology
|
December 3, 2016
From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis
April W Armstrong, Michael P Siegel, Jerry Bagel, et al.
Page
of 30